Hengrui Medicine is a prominent pharmaceutical corporation situated in China, focusing on the exploration, production, manufacturing, and marketing of groundbreaking and superior healthcare goods. It underwent restructuring into a joint-stock company in 1997 and was subsequently listed on the Shanghai Stock Exchange under stock code 600276 in 2000. With a market capitalization exceeding 55 billion USD, the company is ranked among the top 30 pharmaceutical firms globally and employs over 21,900 personnel worldwide. Hengrui is recognized as a pioneer in the field of cancer medications, contrast agents, and surgical innovations.
Products & Services
Azelastine Hydrochloride
Azelastine Hydrochloride Non Sterile Bulk Drug Substance
Bupivacaine
Bupivacaine Base
Sites
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Audited
Country
People's Republic of ChinaCity
Lianyungang
Platinum
2024 Qualifyze Quality Compliance Rating2024 Qualifyze QCRJIANGSU HENGRUI MEDICINE CO. LTD
Audited
Country
People's Republic of ChinaAddress
Huang He Lu, Huang Pu Qu, Shang Hai Shi, China
Jiangsu Hengrui Pharmaceuticals
Country
People's Republic of ChinaCity
Lianyungang
Jiangsu Hengrui Medicine
Country
People's Republic of ChinaJiangsu Hengrui Medicine
Country
People's Republic of ChinaCity
Lian Yun Gang Shi
Address
Zhen Xing Lu, 222062